• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Roux-en-Y胃旁路手术可改善非酒精性脂肪性肝病患者的肝脏组织学。

Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease.

作者信息

Clark Jeanne M, Alkhuraishi Amir R A, Solga Steven F, Alli Patricia, Diehl Anna Mae, Magnuson Thomas H

机构信息

Welch Center for Prevention, Epidemiology and Clinical Research, The Johns Hopkins University, 2024 E. Monument Street, Suite 2-600, Baltimore MD 21205, USA.

出版信息

Obes Res. 2005 Jul;13(7):1180-6. doi: 10.1038/oby.2005.140.

DOI:10.1038/oby.2005.140
PMID:16076987
Abstract

OBJECTIVES

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver disease in the United States and is prevalent in morbidly obese patients. While weight loss and treatment of risk factors are recommended, the reported effects of bariatric surgery on NAFLD are mixed.

RESEARCH METHODS AND PROCEDURES

We examined liver histology at the time of Roux-en-Y gastric bypass surgery and at elective incisional hernia repair after weight loss for 16 patients at one center. Slides were read by one pathologist, blinded to clinical data, using the Brunt criteria. Clinical and laboratory data were extracted from chart review. Alcohol use was ascertained by two interviews.

RESULTS

At baseline, the mean age was 44 years, 50% were women, 88% were white, and the mean BMI was 51 kg/m2. None had significant alcohol use. On initial biopsy, all patients showed steatosis, 94% had inflammation, 88% had ballooning degeneration, 88% had perisinusoidal fibrosis, and 81% had portal fibrosis. The mean time between the two biopsies was 305 +/- 131 (SD) days. The mean weight loss was 118 +/- 29 lb. Steatosis improved in 15 of 16 patients, with resolution in 13. Twelve of 15 patients with inflammation at baseline showed improvement, and 12 of 14 showed less ballooning. Six of 14 patients with perisinusoidal fibrosis and 6 of 13 with portal fibrosis showed improvement. No patient had worsening of steatosis, inflammation, ballooning, or fibrosis.

DISCUSSION

Our study shows improvement in all of the histological features of NAFLD after Roux-en-Y gastric bypass surgery-induced weight loss, despite significant histopathology at baseline and substantial weight loss.

摘要

目的

非酒精性脂肪性肝病(NAFLD)是美国肝病最常见的病因,在病态肥胖患者中很普遍。虽然建议进行体重减轻和危险因素治疗,但关于减肥手术对NAFLD的影响报道不一。

研究方法和步骤

我们在一个中心对16例患者进行了Roux-en-Y胃旁路手术时和减肥后择期切口疝修补时的肝脏组织学检查。由一名病理学家在不知道临床数据的情况下,根据布伦特标准阅读切片。从病历回顾中提取临床和实验室数据。通过两次访谈确定饮酒情况。

结果

基线时,平均年龄为44岁,50%为女性,88%为白人,平均体重指数为51kg/m²。均无大量饮酒。初次活检时,所有患者均有脂肪变性,94%有炎症,88%有气球样变性,88%有窦周纤维化,81%有门脉纤维化。两次活检之间的平均时间为305±131(标准差)天。平均体重减轻118±29磅。16例患者中有15例脂肪变性改善,13例消退。基线时有炎症的15例患者中有12例改善,14例中有12例气球样变性减轻。14例窦周纤维化患者中有6例改善,13例门脉纤维化患者中有6例改善。无患者脂肪变性、炎症、气球样变性或纤维化加重。

讨论

我们的研究表明,尽管基线时组织病理学明显且体重减轻显著,但Roux-en-Y胃旁路手术导致体重减轻后,NAFLD的所有组织学特征均有改善。

相似文献

1
Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease.Roux-en-Y胃旁路手术可改善非酒精性脂肪性肝病患者的肝脏组织学。
Obes Res. 2005 Jul;13(7):1180-6. doi: 10.1038/oby.2005.140.
2
Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.非酒精性脂肪性肝炎和非酒精性脂肪性肝病的外科治疗。
Dig Dis. 2010;28(1):274-9. doi: 10.1159/000282102. Epub 2010 May 7.
3
Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity.Roux-en-Y胃旁路手术可改善病态肥胖患者的非酒精性脂肪性肝炎(NASH)。
Obes Surg. 2006 Mar;16(3):270-8. doi: 10.1381/096089206776116462.
4
Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery.非酒精性脂肪性肝炎:Roux-en-Y胃旁路手术的效果
Am J Gastroenterol. 2006 Feb;101(2):368-73. doi: 10.1111/j.1572-0241.2006.00419.x.
5
Liver pathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery.接受Roux-en-Y胃旁路手术的病态肥胖患者的肝脏病理学
Obes Surg. 2002 Feb;12(1):49-51. doi: 10.1381/096089202321144577.
6
Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.减肥手术对非酒精性脂肪性肝病的影响:2年后的初步结果。
J Gastroenterol Hepatol. 2007 Apr;22(4):510-4. doi: 10.1111/j.1440-1746.2007.04833.x.
7
Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass.接受Roux-en-Y胃旁路手术的病态肥胖患者肝脏左右叶之间的组织病理学变异性。
Clin Gastroenterol Hepatol. 2007 Nov;5(11):1329-32. doi: 10.1016/j.cgh.2007.06.005. Epub 2007 Aug 16.
8
Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.病态肥胖的肝脏组织病理学:其他形式慢性肝病的并发情况。
Obes Surg. 2006 Dec;16(12):1584-93. doi: 10.1381/096089206779319392.
9
Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement.体重减轻与非酒精性脂肪性肝病:γ-谷氨酰转移酶浓度下降与组织学改善相关。
Obes Surg. 2006 Oct;16(10):1278-86. doi: 10.1381/096089206778663805.
10
Review article: Non-alcoholic fatty liver disease in morbidly obese patients and the effect of bariatric surgery.综述文章:病态肥胖患者的非酒精性脂肪性肝病及减肥手术的影响
Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:195-201. doi: 10.1111/j.1365-2036.2007.03483.x.

引用本文的文献

1
Foregut bypass restrictive bariatric procedures for nonalcoholic fatty liver disease: a meta-analysis of 3,355 individuals.用于非酒精性脂肪性肝病的前肠转流限制性减肥手术:对3355例个体的荟萃分析
Hepatobiliary Surg Nutr. 2023 Oct 1;12(5):658-670. doi: 10.21037/hbsn-21-520. Epub 2022 Jun 20.
2
Mechanisms linking bariatric surgery to adipose tissue, glucose metabolism, fatty liver disease and gut microbiota.肥胖症手术与脂肪组织、葡萄糖代谢、脂肪肝疾病和肠道微生物组的关联机制。
Langenbecks Arch Surg. 2023 Feb 24;408(1):101. doi: 10.1007/s00423-023-02821-8.
3
Diet-induced gut dysbiosis and inflammation: Key drivers of obesity-driven NASH.
饮食诱导的肠道菌群失调与炎症:肥胖驱动的非酒精性脂肪性肝炎的关键驱动因素。
iScience. 2022 Dec 30;26(1):105905. doi: 10.1016/j.isci.2022.105905. eCollection 2023 Jan 20.
4
Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment.瘦/非肥胖和肥胖个体中的非酒精性脂肪性肝病:关于患病率、发病机制、临床结局及治疗的综合综述
J Clin Transl Hepatol. 2023 Apr 28;11(2):502-515. doi: 10.14218/JCTH.2022.00204. Epub 2022 Dec 23.
5
The Effect of Laparoscopic Sleeve Gastrectomy and Gastric Bypass Surgery on Non-Alcoholic Steatohepatitis in Iranian Patients with Obesity.腹腔镜袖状胃切除术和胃旁路手术对伊朗肥胖患者非酒精性脂肪性肝炎的影响。
Middle East J Dig Dis. 2021 Jul;13(3):200-207. doi: 10.34172/mejdd.2021.226. Epub 2021 May 11.
6
Bariatric Surgery Improves Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis.减肥手术可改善非酒精性脂肪性肝病:系统评价与荟萃分析。
Obes Surg. 2022 Jun;32(6):1872-1883. doi: 10.1007/s11695-022-06011-1. Epub 2022 Apr 6.
7
Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review.非酒精性脂肪性肝病(NAFLD)与减肥/代谢手术作为其治疗选择:综述
J Clin Med. 2021 Dec 7;10(24):5721. doi: 10.3390/jcm10245721.
8
Efficacy and safety of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy in obese subjects with Non-Alcoholic SteatoHepatitis (NASH): study protocol for a randomized controlled trial (TESLA-NASH study).内镜袖状胃成形术与腹腔镜袖状胃切除术治疗非酒精性脂肪性肝炎(NASH)肥胖患者的疗效和安全性:一项随机对照试验(TESLA-NASH 研究)的研究方案。
Trials. 2021 Oct 30;22(1):756. doi: 10.1186/s13063-021-05695-7.
9
New targets for NAFLD.非酒精性脂肪性肝病的新靶点
JHEP Rep. 2021 Aug 8;3(6):100346. doi: 10.1016/j.jhepr.2021.100346. eCollection 2021 Dec.
10
Therapeutic approaches for non-alcoholic steatohepatitis.非酒精性脂肪性肝炎的治疗方法。
Ther Adv Endocrinol Metab. 2021 Sep 3;12:20420188211034300. doi: 10.1177/20420188211034300. eCollection 2021.